TheProfitWatch

ZBIO - Zenas BioPharma, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
26.69 -0.29 (-1.09%) --- --- --- 0.31 (1.16%) 0.14 (0.52%) -1.12 (-4.07%) -1.12 (-4.07%)

Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-1.25
Diluted EPS:
-1.25
Basic P/E:
-21.12
Diluted P/E:
-21.12
RSI(14) 1m:
0.0
VWAP:
26.4
RVol:
1.3981

Events

Period Kind Movement Occurred At
1m Price decrease 1m 26.42 -0.58 (-2.15%) Oct 15 09:31
1m Price increase 1m 27.26 +0.57 (+2.14%) Oct 15 07:25

Related News